Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Aripiprazole in Major Depressive Disorder
NCT00095758Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Sep 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in major depressive disorder (MDD), sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Sep 2004; status: completed.
02
Drugs
aripiprazole
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00095758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00095758.